Mutares Heads Into Late-June Gauntlet With a No-Cash Deal and a Dividend Question

The coming week will test whether Mutares can simultaneously clear a covenant hurdle, integrate a loss-making Czech chemicals plant, and explain to shareholders why a bumper earnings year won’t trigger an extra payout. The Münich-based holding company acquired Synthomer a.s. from Synthomer plc for a headline price of zero euros on June 19, taking over the troubled acrylics operation in Sokolov.

A Carve-Out Priced for Turnaround

No cash exchanged hands at signing, which is standard for Mutares’ special‑situation playbook. Instead, Synthomer plc can earn up to €12 million over three years, dependent on the cash the business actually throws off. The seller had already classified the acrylate unit as non-core back in 2022, and the buyer is betting its operational turnaround skills can reverse the red ink. In 2025, the plant generated external revenues of €68 million and an adjusted EBITDA loss of €10 million. By early 2026, however, the unit had swung into profit, giving Mutares a basis to build on.

The deal adds a second pillar to the company’s Chemicals & Materials segment, following the January acquisition of SABIC’s engineering thermoplastics business for an enterprise value of $450 million. Completion is slated for the third quarter of 2026, with supply agreements between Synthomer a.s. and its former parent set to continue.

Covenant Clock Ticks Toward June 29

A more immediate concern lands on June 29, when a suspended bond covenant comes up for formal review. The test centres on whether the Wärtsilä Gas Solutions acquisition has improved the net‑debt‑to‑equity ratio enough to meet the threshold before the waiver expires. Management has expressed confidence that the figure will come in well below the required level. In parallel, Mutares is running a tender offer for up to 10% of its floating‑rate note at 101% of par, and from the second quarter onward it plans to execute quarterly bond buybacks of at least €25 million.

The stock closed Friday at €29.40, a 3.70% gain for the session. That puts it comfortably above its 50‑day moving average of €26.70, with a monthly advance of 9.29% – a recovery from its April low of €23.30, which now sits 26% lower in the rearview mirror. The 200‑day line is at €28.96, a level the shares broke above in mid‑June and have held since. The relative strength index of 63.5 leaves room for further upside without signalling overbought conditions, though the 52‑week high of €36.75 remains a 20% climb away.

Should investors sell immediately? Or is it worth buying Mutares?

Dividend Story: Solid Base, No Bonus

At the annual general meeting on July 3, the board is proposing a dividend of €2.00 per share, which Mutares explicitly brands as a minimum dividend. For income‑focused investors the yield on the current price is respectable, but the lack of a performance dividend – the extra payout promised when exits deliver substantial earnings and cash – is the elephant in the room. Despite a strong 2025 performance – group revenue rose to €6.5 billion and EBITDA jumped from €117 million to €675 million – the bonus component remains absent. Shareholders hoping for a special distribution will leave empty‑handed.

The AGM gives management a platform to explain why the model still makes sense. The exit pipeline is the engine of Mutares’ value creation. In June, the company agreed to sell NEM Energy B.V. and its unit NEM Balcke‑Dürr GmbH to Hyundai Heavy Industries Power Systems, a deal expected to close in the third quarter subject to regulatory approval. Mutares carved NEM out of Siemens Energy in December 2022 and turned it into a profitable standalone platform. That disposal joins earlier exits such as Terranor, Walor Precision Turning and parts of the F.lli Ferrari business.

Analyst Caution Tempered by Pipeline Promise

Warburg Research recently cut its price target from €46 to €41 while maintaining a buy rating, reflecting a realistic recalibration of expectations without abandoning faith in the model. Professional observers see the turnaround machinery intact, but the share price has not yet fully priced in the recent exit activity.

For the current year, Mutares projects group revenue of between €7.9 billion and €9.1 billion, with a holding‑level net profit of €165 million to €200 million. It expects exit proceeds to significantly exceed last year’s figure of roughly €230 million. The July 3 meeting will therefore be less about the €2.00 dividend and more about whether management can convince the market that the pipeline is on track to deliver those targets – and that a performance dividend may eventually follow.